Cantor Fitzgerald keeps USD 15.00 target for Trulieve Cannabis stock

Published on 10/25/2026 at 13:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cantor Fitzgerald kept its Overweight rating and USD 15.00 target on October 23, 2026. For Trulieve Cannabis stock, Q3 results arrive November 5, 2026.

Debt reduction and analyst view

Cantor Fitzgerald maintained an Overweight rating and a USD 15.00 target on October 23, 2026.
Second-quarter 2026 revenue reached USD 271.00 million, while adjusted earnings per share came to USD 0.11.
Trulieve will publish third-quarter 2026 results on November 5, 2026.
Market capitalization stood at USD 1.8 billion on October 23, 2026.

TRUL, US89790E1064, Illustration mit AI erstellt.

Trulieve Cannabis (ISIN US89790E1064) had a USD 15.00 price target and an Overweight rating reaffirmed by Investing.com on October 23, 2026. The company will publish third-quarter 2026 results on November 5, according to Trulieve.

Three events shape the setup

On August 7, 2026, Trulieve reported second-quarter revenue of USD 271.00 million and adjusted earnings per share of USD 0.11, according to Investing.com. On October 7, the company repaid a USD 65.00 million mortgage, reducing outstanding debt to USD 225.00 million, Trulieve said.

On October 23, Cantor Fitzgerald maintained its Overweight rating and USD 15.00 target, according to Investing.com. The unchanged target keeps the analyst view focused on operating scale and the effect of lower debt costs.

What does the target imply?

The USD 15.00 target sits above the USD 10.42 last-traded NYSE level on October 23, 2026, while second-quarter revenue of USD 271.00 million was below the USD 272.21 million estimate cited by Investing.com. That combination leaves the November report important for testing whether debt reduction is translating into improved earnings quality.

Results date sets the next checkpoint

Trulieve is scheduled to release third-quarter 2026 results on November 5, 2026, followed by an 8:30 a.m. ET conference call with CEO Kim Rivers and CFO Jan Reese, according to Trulieve.

Market value and range

Trulieve last traded at USD 10.42 on the NYSE on October 23, 2026 at 4:00 p.m. ET. Its 52-week range was USD 3.25 to USD 13.28 and market capitalization was USD 1.8 billion on that date. The further course of trading is shown by the continuously updated real-time quote of Trulieve Cannabis stock.